Search
Spotlight
CME Opportunities
CME Opportunities
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
OncClub
All Oncology News
Media
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Insights
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Giants of Cancer Care
CME/CE
Scientific Interchanges
State of the Science Summit / IPC
National Fellows Forum
Webinars
Partners
Publications
Resources
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Consensus Viewpoints
OncLive App
Interactive Tools
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
CME Opportunities
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Yale Cancer Center Smilow Cancer Hospital - Episode 1
Yale Cancer Center Merges Cutting Edge Research with Personalized Medicine
November 21, 2015
Now Viewing
EP. 1: Yale Cancer Center Merges Cutting Edge Research with Personalized Medicine
EP. 2: Dr. Decker on Pembrolizumab With Concurrent Chemoradiotherapy in Inoperable Locally Advanced NSCLC
EP. 3: Dr. Anees Chagpar Named 2021 ASCO Fellow
EP. 4: Yale Cancer Center’s Dr. Lieping Chen Elected to Prestigious National Academy of Sciences
EP. 5: Yale Research to be Presented at 2021 ASCO Annual Meeting
EP. 6: Dr. Bewersdorf on the Role of Allogeneic Transplant in Myelofibrosis
EP. 7: Barbara Burtness Named Interim Associate Director for Diversity, Equity, and Inclusion at Yale Cancer Center
EP. 8: Joseph W. Kim Receives Prestigious 2021 Cancer Clinical Investigator Team Leadership Award
EP. 9: Yale Cancer Center Perspective Highlights New Advances for NSCLC
EP. 10: Yale Cancer Center Study Shows Stem-Like T Cells Could Aid Immunotherapy in Cancer Treatment
EP. 11: Dr. Silber on the Importance of Improving Clinical Trial Inclusivity in Breast Cancer
EP. 12: Dr. Lustberg Discusses Ongoing Research in Breast Cancer
EP. 13: Margaret Gilshannon named Deputy Director for Finance & Administration at Yale Cancer Center
EP. 14: Tissue Mapping Center for Cellular Senescence Launched at Yale Cancer Center to Study Human Lymphoid Organs
EP. 15: Eric P. Winer to lead Yale Cancer Center and Smilow Cancer Hospital
EP. 16: Dr. Parker Discusses the Importance of Optimizing Treatment in Multiple Myeloma
EP. 17: Yale Cancer Center Study Shows New Strategy to Boost Immune System to Fight Melanoma
EP. 18: Dr. Fernandez on the Need to Refine Immunohistochemistry Testing in HER2+ Breast Cancer
EP. 19: Dr. Fernandez on the Utility of Trastuzumab Deruxtecan in HER2-Low Breast Cancer
EP. 20: Immunotherapy Advances Drive Progress in Lung Cancer Treatment
EP. 21: Ian E. Krop, MD, PhD, Named Chief Clinical Research Officer, Associate Cancer Center Director for Clinical Research at Yale Cancer Center
EP. 22: Yale Cancer Center Study Reveals Disparities in Telemedicine Use in Patients with Hematologic Cancers
EP. 23: Addition of Bevacizumab to Ixabepilone Is Effective, Tolerable in Platinum-Resistant Ovarian Cancer
EP. 24: Dr. Petrylak on the Rationale of the EV-103 Trial in MIBC
EP. 25: Yale Cancer Center and School of Public Health Receive Grant to Study Lifestyle Intervention in Women with Ovarian Cancer
EP. 26: Berzosertib Plus Standard Chemoradiation Elicits Promising Responses in Locally Advanced HNSCC
EP. 27: Barbara Burtness Named Chief Translational Research Officer for Yale Cancer Center and Smilow Cancer Hospital
EP. 28: Expert Insights on First-line Treatment Strategies in SCLC
EP. 29: Combination Therapy Approaches With Chemotherapy and Immunotherapy in ES-SCLC
EP. 30: ADRIATIC Trial and Investigational Treatment Approaches for Limited-Stage SCLC
EP. 31: Patient Scenario 2: 1L Management of ES-SCLC Positive for Synaptophysin With a Ki-67 Score of 90%
EP. 32: Real World Data for Combination Strategies With Chemotherapy and Immunotherapy in ES-SCLC
EP. 33: Patient Scenario 3: 2L Lurbinectedin Following 1L Combination IO Chemotherapy
EP. 34: Evolving Treatment Strategies for SCLC in the Second-Line Setting and Beyond
EP. 35: LAGOON and IMFORTE Trials: Data Updates and Expert Insights
EP. 36: 2L Dosing Considerations and Management Strategies for SCLC
EP. 37: Novel Treatment Approaches for SCLC and Future Perspectives
Related Content:
Yale Cancer Center Smilow Cancer Hospital
Precision Medicine in Oncology®
Special Reports in Personalized Cancer Care
Targeted CAR T-Cell Therapies Show Early Efficacy in Solid Tumors With Focus on Mitigating Toxicity
Five Under 5: Top Oncology Videos for the Week of 5/4
The OncFive: Top Oncology Articles for the Week of 5/4
x